Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19
Michael Chait, Mine M. Yilmaz, Shanila Shakil, Amy W. Ku, Pranay Dogra, Thomas J. Connors, Peter A. Szabo, Joshua I. Gray, Steven B. Wells, Masaru Kubota, Rei Matsumoto, Maya M.L. Poon, Mark E. Snyder, Matthew R. Baldwin, Peter A. Sims, Anjali Saqi, Donna L. Farber, Stuart P. Weisberg
Michael Chait, Mine M. Yilmaz, Shanila Shakil, Amy W. Ku, Pranay Dogra, Thomas J. Connors, Peter A. Szabo, Joshua I. Gray, Steven B. Wells, Masaru Kubota, Rei Matsumoto, Maya M.L. Poon, Mark E. Snyder, Matthew R. Baldwin, Peter A. Sims, Anjali Saqi, Donna L. Farber, Stuart P. Weisberg
View: Text | PDF
Research Article Aging COVID-19

Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19

  • Text
  • PDF
Abstract

Respiratory failure in COVID-19 is characterized by widespread disruption of the lung’s alveolar gas exchange interface. To elucidate determinants of alveolar lung damage, we performed epithelial and immune cell profiling in lungs from 24 COVID-19 autopsies and 43 uninfected organ donors ages 18–92 years. We found marked loss of type 2 alveolar epithelial (T2AE) cells and increased perialveolar lymphocyte cytotoxicity in all fatal COVID-19 cases, even at early stages before typical patterns of acute lung injury are histologically apparent. In lungs from uninfected organ donors, there was also progressive loss of T2AE cells with increasing age, which may increase susceptibility to COVID-19–mediated lung damage in older individuals. In the fatal COVID-19 cases, macrophage infiltration differed according to the histopathological pattern of lung injury. In cases with acute lung injury, we found accumulation of CD4+ macrophages that expressed distinctly high levels of T cell activation and costimulation genes and strongly correlated with increased extent of alveolar epithelial cell depletion and CD8+ T cell cytotoxicity. Together, our results show that T2AE cell deficiency may underlie age-related COVID-19 risk and initiate alveolar dysfunction shortly after infection, and we define immune cell mediators that may contribute to alveolar injury in distinct pathological stages of fatal COVID-19.

Authors

Michael Chait, Mine M. Yilmaz, Shanila Shakil, Amy W. Ku, Pranay Dogra, Thomas J. Connors, Peter A. Szabo, Joshua I. Gray, Steven B. Wells, Masaru Kubota, Rei Matsumoto, Maya M.L. Poon, Mark E. Snyder, Matthew R. Baldwin, Peter A. Sims, Anjali Saqi, Donna L. Farber, Stuart P. Weisberg

×

Figure 5

Patterns of immune cell infiltration associated with lung tissue pathology in fatal COVID-19.

Options: View larger image (or click on image) Download as PowerPoint
Patterns of immune cell infiltration associated with lung tissue patholo...
(A) Representative original magnification 20× fields of 7-color multiplex staining with single markers shown for the boxed magnified field, of alveolar lung tissue from uninfected controls (left), early COVID-19 mortality cases without ALI (middle), and late COVID-19 mortality cases with ALI (right). (B) Lung tissue density of immune cell subsets defined based on expression of the 6 immune lineage markers for each of the controls (n = 9–12, blue dots), COVID-19 mortality cases without ALI (n = 9, green dots), and COVID-19 mortality cases with ALI (n = 10–15, red dots). P values were calculated using a mixed effects model 2-way ANOVA and Dunnett’s multiple comparisons test. (C) Representative contour plots depicting granzyme B (GZMB) expression plotted against CD8 expression (left) in the imaged CD8+ T cells of a control and COVID-19 mortality case with compiled data (right). For each case, mortality at early (unfilled dot, n = 8) or late (filled dot, n = 16) stage of disease is also indicated. P values were calculated using Welch’s ANOVA test and Dunnett’s multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars show median and interquartile range. White scale bar, top images 50 μm; single marker images 25 μm. Arrow colors indicate lineages (magenta, macrophage; cyan, CD4+ T cell; orange CD8+ T cell; red, neutrophil; yellow, B cell).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts